{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:27:39Z","timestamp":1790422059976,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T00:00:00Z","timestamp":1566864000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T00:00:00Z","timestamp":1566864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000034","name":"Institute of Neurosciences, Mental Health and Addiction","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100000034","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009192","name":"Alberta Innovates","doi-asserted-by":"crossref","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100009192","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Brain"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13041-019-0493-9","type":"journal-article","created":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T14:29:39Z","timestamp":1566916179000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["SUMOylation regulates USP5-Cav3.2 calcium channel interactions"],"prefix":"10.1186","volume":"12","author":[{"given":"Agustin","family":"Garcia-Caballero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Xiong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said","family":"M\u2019Dahoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0644-9066","authenticated-orcid":false,"given":"Gerald W.","family":"Zamponi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,27]]},"reference":[{"issue":"8","key":"493_CR1","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nrm2731","volume":"10","author":"D Komander","year":"2009","unstructured":"Komander D, Clague MJ, Urbe S. Breaking the chains: structure and function of the deubiquitinases. Nat Rev Mol Cell Biol. 2009;10(8):550\u201363.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"493_CR2","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1152\/physrev.00002.2013","volume":"93","author":"MJ Clague","year":"2013","unstructured":"Clague MJ, Barsukov I, Coulson JM, Liu H, Rigden DJ, Urbe S. Deubiquitylases from genes to organism. Physiol Rev. 2013;93(3):1289\u2013315.","journal-title":"Physiol Rev"},{"issue":"1","key":"493_CR3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bbrc.2017.08.040","volume":"492","author":"XY Li","year":"2017","unstructured":"Li XY, Wu HY, Mao XF, Jiang LX, Wang YX. USP5 promotes tumorigenesis and progression of pancreatic cancer by stabilizing FoxM1 protein. Biochem Biophys Res Commun. 2017;492(1):48\u201354.","journal-title":"Biochem Biophys Res Commun"},{"issue":"39","key":"493_CR4","doi-asserted-by":"publisher","first-page":"66215","DOI":"10.18632\/oncotarget.19882","volume":"8","author":"BP Kaistha","year":"2017","unstructured":"Kaistha BP, Krattenmacher A, Fredebohm J, et al. The deubiquitinating enzyme USP5 promotes pancreatic cancer via modulating cell cycle regulators. Oncotarget. 2017;8(39):66215\u201325.","journal-title":"Oncotarget"},{"issue":"11","key":"493_CR5","first-page":"2284","volume":"8","author":"X Ma","year":"2018","unstructured":"Ma X, Qi W, Pan H, Yang F, Deng J. Overexpression of USP5 contributes to tumorigenesis in non-small cell lung cancer via the stabilization of beta-catenin protein. Am J Cancer Res. 2018;8(11):2284\u201395.","journal-title":"Am J Cancer Res"},{"issue":"5","key":"493_CR6","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.neuron.2014.07.036","volume":"83","author":"A Garcia-Caballero","year":"2014","unstructured":"Garcia-Caballero A, Gadotti VM, Stemkowski P, et al. The deubiquitinating enzyme USP5 modulates neuropathic and inflammatory pain by enhancing Cav3.2 channel activity. Neuron. 2014;83(5):1144\u201358.","journal-title":"Neuron"},{"key":"493_CR7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12990-015-0011-8","volume":"11","author":"VM Gadotti","year":"2015","unstructured":"Gadotti VM, Caballero AG, Berger ND, et al. Small organic molecule disruptors of Cav3.2 - USP5 interactions reverse inflammatory and neuropathic pain. Mol Pain. 2015;11:12. \n                    https:\/\/doi.org\/10.1186\/s12990-015-0011-8\n                    \n                  .","journal-title":"Mol Pain"},{"key":"493_CR8","doi-asserted-by":"publisher","first-page":"174480691664244","DOI":"10.1177\/1744806916642444","volume":"12","author":"Agustin Garcia-Caballero","year":"2016","unstructured":"Garcia-Caballero A, Gadotti VM, Chen L, Zamponi GW. A cell-permeant peptide corresponding to the cUBP domain of USP5 reverses inflammatory and neuropathic pain. Mol Pain. 2016;12. \n                    https:\/\/doi.org\/10.1177\/1744806916642444\n                    \n                  .","journal-title":"Molecular Pain"},{"issue":"545","key":"493_CR9","doi-asserted-by":"publisher","first-page":"eaao4425","DOI":"10.1126\/scisignal.aao4425","volume":"11","author":"Sonja L. Joksimovic","year":"2018","unstructured":"Joksimovic SL, Joksimovic SM, Tesic V, et al. Selective inhibition of CaV3.2 channels reverses hyperexcitability of peripheral nociceptors and alleviates postsurgical pain. Sci Signal. 2018;11(545). \n                    https:\/\/doi.org\/10.1126\/scisignal.aao4425\n                    \n                  .","journal-title":"Science Signaling"},{"issue":"1","key":"493_CR10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13041-018-0405-4","volume":"11","author":"VM Gadotti","year":"2018","unstructured":"Gadotti VM, Zamponi GW. Disrupting USP5\/Cav3.2 interactions protects female mice from mechanical hypersensitivity during peripheral inflammation. Molecular brain. 2018;11(1):60. \n                    https:\/\/doi.org\/10.1186\/s13041-018-0405-4\n                    \n                  .","journal-title":"Molecular brain"},{"issue":"11","key":"493_CR11","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1016\/j.celrep.2016.11.047","volume":"17","author":"P Stemkowski","year":"2016","unstructured":"Stemkowski P, Garc\u00eda-Caballero A, Gadotti VM, al e. TRPV1 nociceptor activity initiates USP5\/T-type channel-mediated plasticity. Cell Rep. 2016;17(11):2901\u201312.","journal-title":"Cell Rep"},{"issue":"2","key":"493_CR12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.bbcan.2018.08.002","volume":"1870","author":"SC Chang","year":"2018","unstructured":"Chang SC, Ding JL. Ubiquitination and SUMOylation in the chronic inflammatory tumor microenvironment. Biochim Biophys Acta Rev Cancer. 2018;1870(2):165\u201375.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"10","key":"493_CR13","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1097\/j.pain.0000000000001294","volume":"159","author":"L Francois-Moutal","year":"2018","unstructured":"Francois-Moutal L, Dustrude ET, Wang Y, et al. Inhibition of the Ubc9 E2 SUMO-conjugating enzyme-CRMP2 interaction decreases NaV1.7 currents and reverses experimental neuropathic pain. Pain. 2018;159(10):2115\u201327.","journal-title":"Pain"},{"issue":"1","key":"493_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/19336950.2017.1370524","volume":"12","author":"A Moutal","year":"2018","unstructured":"Moutal A, Cai S, Luo S, Voisin R, Khanna R. CRMP2 is necessary for Neurofibromatosis type 1 related pain. Channels. 2018;12(1):47\u201350.","journal-title":"Channels"},{"issue":"11","key":"493_CR15","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1038\/mp.2017.117","volume":"23","author":"A Moutal","year":"2018","unstructured":"Moutal A, Dustrude ET, Largent-Milnes TM, Vanderah TW, Khanna M, Khanna R. Blocking CRMP2 SUMOylation reverses neuropathic pain. Mol Psychiatry. 2018;23(11):2119\u201321.","journal-title":"Mol Psychiatry"},{"issue":"52","key":"493_CR16","doi-asserted-by":"publisher","first-page":"E8443","DOI":"10.1073\/pnas.1610531113","volume":"113","author":"ET Dustrude","year":"2016","unstructured":"Dustrude ET, Moutal A, Yang X, Wang Y, Khanna M, Khanna R. Hierarchical CRMP2 posttranslational modifications control NaV1.7 function. Proc Natl Acad Sci U S A. 2016;113(52):E8443\u2013E52.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"493_CR17","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/19336950.2018.1491244","volume":"12","author":"L Fran\u00e7ois-Moutal","year":"2018","unstructured":"Fran\u00e7ois-Moutal L, Scott DD, Perez-Miller S, Gokhale V, Khanna M, Khanna R. Chemical shift perturbation mapping of the Ubc9-CRMP2 interface identifies a pocket in CRMP2 amenable for allosteric modulation of Nav1.7 channels. Channels (Austin). 2018;12(1):219\u201327.","journal-title":"Channels (Austin)"},{"issue":"2","key":"493_CR18","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nn.2712","volume":"14","author":"C Altier","year":"2011","unstructured":"Altier C, Garcia-Caballero A, Simms B, et al. The Cavbeta subunit prevents RFP2-mediated ubiquitination and proteasomal degradation of L-type channels. Nat Neurosci. 2011;14(2):173\u201380.","journal-title":"Nat Neurosci"},{"issue":"5","key":"493_CR19","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.celrep.2015.07.001","volume":"12","author":"Z Zhang","year":"2015","unstructured":"Zhang Z, Gadotti VM, Chen L, Souza IA, Stemkowski PL, Zamponi GW. Role of Prelimbic GABAergic circuits in sensory and emotional aspects of neuropathic pain. Cell Rep. 2015;12(5):752\u20139.","journal-title":"Cell Rep"},{"issue":"51","key":"493_CR20","doi-asserted-by":"publisher","first-page":"43793","DOI":"10.1074\/jbc.M111.267237","volume":"286","author":"L Cong","year":"2011","unstructured":"Cong L, Pakala SB, Ohshiro K, Li DQ, Kumar R. SUMOylation and SUMO-interacting motif (SIM) of metastasis tumor antigen 1 (MTA1) synergistically regulate its transcriptional repressor function. J Biol Chem. 2011;286(51):43793\u2013808.","journal-title":"J Biol Chem"},{"issue":"1","key":"493_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bbrc.2009.07.103","volume":"388","author":"ET Kim","year":"2009","unstructured":"Kim ET, Kim KK, Matunis MJ, Ahn JH. Enhanced SUMOylation of proteins containing a SUMO-interacting motif by SUMO-Ubc9 fusion. Biochem Biophys Res Commun. 2009;388(1):41\u20135.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"493_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-33951-5","volume":"8","author":"CC Chang","year":"2018","unstructured":"Chang CC, Tung CH, Chen CW, Tu CH, Chu YW. SUMOgo: prediction of sumoylation sites on lysines by motif screening models and the effects of various post-translational modifications. Sci Rep. 2018;8(1):15512. \n                    https:\/\/doi.org\/10.1038\/s41598-018-33951-5\n                    \n                  .","journal-title":"Sci Rep"},{"issue":"6","key":"493_CR23","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1021\/bi200854q","volume":"51","author":"GV Avvakumov","year":"2012","unstructured":"Avvakumov GV, Walker JR, Xue S, et al. Two ZnF-UBP domains in isopeptidase T (USP5). Biochemistry. 2012;51(6):1188\u201398.","journal-title":"Biochemistry"},{"issue":"1","key":"493_CR24","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s41467-018-03974-7","volume":"9","author":"Y Wang","year":"2018","unstructured":"Wang Y, Gao Y, Tian Q, et al. TRPV1 SUMOylation regulates nociceptive signaling in models of inflammatory pain. Nat Commun. 2018;9(1):1529. \n                    https:\/\/doi.org\/10.1038\/s41467-018-03974-7\n                    \n                  .","journal-title":"Nat Commun"},{"issue":"4","key":"493_CR25","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1080\/19336950.2017.1311758","volume":"11","author":"A Baumann","year":"2017","unstructured":"Baumann A, Kursula P. SUMO on CRMPs - wrestling for pain? Channels. 2017;11(4):265\u20137.","journal-title":"Channels"},{"key":"493_CR26","doi-asserted-by":"publisher","unstructured":"Moutal A, White KA, Chefdeville A, et al. Dysregulation of CRMP2 post-translational modifications drive its pathological functions. Mol Neurobiol. 2019. \n                    https:\/\/doi.org\/10.1007\/s12035-019-1568-4\n                    \n                  .","DOI":"10.1007\/s12035-019-1568-4"}],"container-title":["Molecular Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-019-0493-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13041-019-0493-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-019-0493-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T23:09:12Z","timestamp":1598396952000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularbrain.biomedcentral.com\/articles\/10.1186\/s13041-019-0493-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,27]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["493"],"URL":"https:\/\/doi.org\/10.1186\/s13041-019-0493-9","relation":{},"ISSN":["1756-6606"],"issn-type":[{"value":"1756-6606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,27]]},"assertion":[{"value":"29 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"73"}}